Seattle Flow Your front door to Seattle's startup scene.
Sign in
Stream Events Podcasts Videos Communities
Lisa Stiffler / GeekWire

Seattle Biotech Startup Curi Bio Raises $10M Led by DreamCIS to Advance 3D Tissue Drug Discovery Platforms

Seattle biotech startup Curi Bio raised $10 million in Series B funding led by DreamCIS to expand its R&D platform using 3D tissue models for drug discovery. The company serves major pharmaceutical firms and aims to develop new platforms for various muscle and metabolic diseases.

CCuri Bio
  • Link
  • Report this item
Replying to

No comments yet.

Seattle Flow — Your front door to Seattle's startup scene.

Run by Marcelo Calbucci MC
Send us a link Terms of Service Privacy For AI assistants
© 2026 Seattle Flow. All rights reserved.

Who liked this

Edit history

Seattle Flow

Your front door to Seattle's startup scene.

Seattle's startup scene is scattered across a hundred feeds, newsletters, and calendars. Seattle Flow brings it together: the news, events, podcasts, and people, plus what the community is saying about them. Every link sends you to the source.

Writing about a Seattle founder, fund, or startup? We'll help it get seen. Found a great story we missed? Send it in.

We're in beta and building this with the community. Tell us what you want to see here.

Seattle's startup scene, every day. The news, events, podcasts, and people, plus what everyone's saying about them. We're in beta: send us a story or tell us what you want to see.